Dr. Thomas Julian Ow, MD

Dr. Ow practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Ow's NPI, 1891094850, was assigned on March 16, 2011. Dr. Ow graduated from Feinberg School of Medicine in 2004. Dr. Ow's New York license number on file is 266122.

Dr. Ow's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Ow's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Ow to 2 more group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account. Dr. Ow's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ow practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Ow's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Ow is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Ow's licenses on file in 2 states: New York and Texas.

Dmand AI lists larynx and vocal cord disease and thyroid surgery among the conditions Dr. Ow treats.

CMS data shows 152 Medicare services from Dr. Ow across 3 procedure codes in 2024, for 85 Medicare patients. Medicare paid $9,450 for them. Every service was in an office.

CMS counts 85 Medicare patients who saw Dr. Ow in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 49% are also on Medicaid. Their average risk score is 3.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ow's median patient age at 73, with 47% women.

In 2024, Dr. Ow wrote 101 Medicare Part D claims for 38 patients. 96% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $74 in total drug cost. In 2022, CMS named 45 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ow for performance year 2024, reported as part of a group. Dr. Ow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ow as offering telehealth. CMS counts 49 procedures of melanoma (skin cancer) excision by Dr. Ow, more than 86% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 105 papers to Dr. Ow, published from 2010 to 2025. 2018 was the busiest year, with 10. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Squamous Cell Carcinoma of Head and Neck. Dr. Ow has published most often in Laryngoscope. Dr. Ow's most frequent co-authors are Richard V. Smith, MD, Bradley Alan Schiff, MD and Jeffrey N. Myers, FACS, MD, PhD.

Dmand AI links Dr. Ow to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Head and Neck Neoplasms.

CMS Open Payments shows 2 general payments to Dr. Ow from 2 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Optinose US, Inc. paid the most, $24.

Dr. Ow graduated from Feinberg School of Medicine in 2004. Dr. Ow is a member of NHS.

Dr. Ow is in network with 10 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.